Broadcast

e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

About

The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
 

Articles

Obesity Management and Cardiovascular Disease

Published:

09 April 2026

Citation:

European Cardiology Review 2026;21:e17.

Targeting Obesity for Heart Failure

Published:

23 December 2025

Citation:

European Cardiology Review 2025;20:e38.

Malnutrition and Prognosis in Elderly Patients with Chronic Heart Failure

Published:

20 October 2025

Citation:

Cardiac Failure Review 2025;11:e26.

Obesity and CKD: The Dual Epidemic in Cardiovascular Health

Published:

17 October 2025

Citation:

European Cardiology Review 2025;20:e28.